Trexquant Investment’s bluebird bio BLUE Stock Holding History

Trexquant Investment’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,362	Closed	-$564K	–	1142
2021 Q2	$564K	Buy	+1,362	New	+$540K	0.05%	457
2020 Q4	–	Sell	-698	Closed	-$488K	–	1038
2020 Q3	$488K	Sell	698 -1,324	-65%	-$1.03M	0.03%	696
2020 Q2	$1.6M	Sell	2,022 -236	-10%	-$178K	0.11%	255
2020 Q1	$1.34M	Buy	+2,258	New	+$2.2M	0.1%	316
2018 Q1	–	Sell	-616	Closed	-$1.42M	–	1080
2017 Q4	$1.42M	Buy	+616	New	+$1.25M	0.16%	198
2017 Q3	–	Sell	-216	Closed	-$294K	–	780
2017 Q2	$294K	Buy	+216	New	+$261K	0.08%	476
2016 Q2	–	Sell	-1,621	Closed	-$893K	–	881
2016 Q1	$893K	Buy	+1,621	New	+$996K	0.1%	330
2015 Q3	–	Sell	-741	Closed	-$1.61M	–	1046
2015 Q2	$1.61M	Buy	741 +396	+115%	+$807K	0.18%	160
2015 Q1	$539K	Buy	+345	New	+$455K	0.06%	657

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Trexquant Investment's BLUE Position: Q3 2021 in Review

Trexquant Investment sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 1,362 shares — an estimated $564K sold.

Trexquant Investment first reported a position in BLUE in Q1 2015 and held it in 9 quarters. The position peaked at $1.61M in Q2 2015. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

Trexquant Investment reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
Trexquant Investment sold 1,362 bluebird bio shares in Q3 2021, an estimated $564K.
Trexquant Investment first reported a position in bluebird bio in Q1 2015 and held it in 9 quarters.
Trexquant Investment's bluebird bio position peaked at $1.61M in Q2 2015.
196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.